Alterity Therapeutics Insider Trades
NASDAQ: ATHEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $23.81K
- Sales
- 0 · $0
- Shares bought / sold
- 47.62K / 0
- Net activity
- Net buying $23,810
Alterity Therapeutics insider activity
Over the last 12 months, Alterity Therapeutics insiders reported 1 transaction on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $23,810 and sold $0 worth of stock, for net insider buying of $23,810. The most recent filing shows Marks Peter Ashley (Director) buying 47,620 shares at $0.50 on Aug 31, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ATHE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ATHE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 31, 2026 | Marks Peter AshleyDirector | Buy | 47,620 | $23.81K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4